NGM282: Clinical Trials

4 trials of NGM282, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 14Completed 4
Phase 21Completed 1

Follow NGM282: new trials by email Literature Review of NGM282 trials Research Report on NGM282

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Aldafermin (NGM282) in Healthy Adult Male Japanese and Non-Japanese Subjects
Aldafermin - Healthy Male
Phase 1CompletedNGM Biopharmaceuticals, Inc362021-04-132022-01-31
Study of Aldafermin (NGM282) in Participants With Impaired Hepatic Function
Aldafermin - Impaired Hepatic Function
Phase 1CompletedNGM Biopharmaceuticals, Inc362021-04-012022-01-19
Study of NGM282 in Subjects With Functional Constipation and Healthy Individuals
NGM282, Placebo - Functional Constipation
Phase 1 / Phase 2CompletedNGM Biopharmaceuticals, Inc312015-12-012018-03-30
Phase 1 SAD and MAD Study of NGM282 in Healthy Adult Participants
NGM282, Placebo - Diabetes Mellitus
Phase 1CompletedNGM Biopharmaceuticals, Inc1192013-01-012013-12-31

Conditions studied

Diabetes Mellitus (1)

Sponsors

NGM Biopharmaceuticals, Inc (4)

Countries

United States (3)  ·  Australia (1)

Top investigators

Alex M DePaoli, MD (1)  ·  Stephen J Rossi, PharmD (1)